These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6027510)

  • 1. Deferoxamine and sweat iron.
    Apte SV
    Proc Soc Exp Biol Med; 1967 May; 125(1):117-8. PubMed ID: 6027510
    [No Abstract]   [Full Text] [Related]  

  • 2. [Deferoxamine in hemosiderosis. Fecal iron excretion during continuous subcutaneous infusion].
    Krüger N; Kijewski H; König R; Tillmann W; Schröter W
    Dtsch Med Wochenschr; 1984 Nov; 109(44):1682-5. PubMed ID: 6489181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersiderosis.
    Walsh JR; Mass RE
    Med Times; 1967 Apr; 95(4):363-9. PubMed ID: 6021601
    [No Abstract]   [Full Text] [Related]  

  • 4. [Desferrioxamine-B in the diagnosis of hemosiderotic states and in the therapy of thalassemia. Apropos of 2 cases].
    De Luca G; Faelli U; Petrussa I
    Minerva Pediatr; 1966 Oct; 18(32):1920-5. PubMed ID: 5993655
    [No Abstract]   [Full Text] [Related]  

  • 5. Fish as models for hemosiderosis.
    Cheung PJ; Nigrelli RF; Ruggieri GD; Gold K; Baiardi JC
    Ann N Y Acad Sci; 1980; 344():336-51. PubMed ID: 6930875
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of desferrioxamine B on tissue sections of hemosiderosis of the kidney].
    Althoff H
    Arzneimittelforschung; 1966 Jun; 16(6):768-71. PubMed ID: 4170766
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in urinary iron in thalassemia major in relation to the administration of desferrioxamine].
    Esposito L; Ferrara M; Galdo Capotorti M
    Pediatria (Napoli); 1978 Mar; 86(1):69-76. PubMed ID: 683795
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of the site of action of deferoxamine.
    Brown EB; Hwang YF; Allgood JW
    J Lab Clin Med; 1967 Mar; 69(3):382-404. PubMed ID: 6019401
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative evaluation of two models of hemosiderosis for analysis of iron chelators].
    Minina LT; Prostakova TM; Meshchano AIu; Kol'tsova GN; Bovenko VN
    Biull Eksp Biol Med; 1996 Sep; 122(9):359-60. PubMed ID: 8974501
    [No Abstract]   [Full Text] [Related]  

  • 10. [Specific treatment of excessive iron deposition in the tissues].
    Plachecka-Gutowska M; Mikolajew M
    Pol Arch Med Wewn; 1965; 35(1):111-7. PubMed ID: 5900073
    [No Abstract]   [Full Text] [Related]  

  • 11. Ultrastructural study of iron deposition in the eccrine sweat glands of patients with iron overload.
    Falanga V; Zheng P; Lavker RM
    Br J Dermatol; 1984 Jan; 110(1):51-6. PubMed ID: 6691917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined long-term treatment of hemosiderosis with desferioxamine and DTPA in homozygous beta-thalassemia.
    Constantoulakis M; Economidou J; Karagiorga M; Katsantoni A; Gyftaki E
    Ann N Y Acad Sci; 1974; 232(0):193-200. PubMed ID: 4528481
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of storage iron by chelates.
    Harker LA; Funk DD; Finch CA
    Am J Med; 1968 Jul; 45(1):105-15. PubMed ID: 5658862
    [No Abstract]   [Full Text] [Related]  

  • 14. "Desferrioxamine-B" test for detecting excess iron storage in man.
    Sinniah R
    Ir J Med Sci; 1968 Jun; 7(6):269-74. PubMed ID: 5662352
    [No Abstract]   [Full Text] [Related]  

  • 15. Deferoxamine in measurement of iron stores.
    Nutr Rev; 1968 Jul; 26(7):205-7. PubMed ID: 4875017
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of hemosiderosis with deferoxamine].
    Strohmeyer G; Stremmel W
    Dtsch Med Wochenschr; 1984 Nov; 109(44):1669-70. PubMed ID: 6489179
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of hemosiderosis in thalassaemia major with desferrioxamine-B.
    Kirimlidis S; Philippidis P; Drossos C; Economidis J
    Helv Paediatr Acta; 1966 Sep; 21(4):343-50. PubMed ID: 5997620
    [No Abstract]   [Full Text] [Related]  

  • 18. [The deferoxamine test].
    Neuwirtová R; Setková O; Dufek M
    Cas Lek Cesk; 1970 Jan; 109(2):40-2. PubMed ID: 5412522
    [No Abstract]   [Full Text] [Related]  

  • 19. Methods for evaluating iron stores and efficacy of chelation in transfusional hemosiderosis.
    Borgna-Pignatti C; Castriota-Scanderbeg A
    Haematologica; 1991; 76(5):409-13. PubMed ID: 1806447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship.
    Silliman CC; Peterson VM; Mellman DL; Dixon DJ; Hambidge KM; Lane PA
    J Lab Clin Med; 1993 Jul; 122(1):48-54. PubMed ID: 8320490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.